Home » Topics » BioWorld Science

BioWorld Science
RSS

Zambon selects a dopaminergic compound for evaluation in cardiovascular/renal disorders

Sep. 6, 1996

New angiotensin II antagonists from Kotobuki

Sep. 6, 1996

alpha1-Adrenoceptor blockers with advantages over prazosin

Sep. 6, 1996

Fujisawa discloses vasopressin antagonists

Sep. 6, 1996

Orally active dual NK1/NK2 antagonist from Merck & Co.

Sep. 6, 1996

SmithKline Beecham stresses dual PDE IV and TNF production inhibitors

Sep. 6, 1996

Bock Pharmacal introduces antihistamine-free cough syrup

Sep. 6, 1996

Clearance for Schering-Plough's extended-release Claritin-D

Sep. 6, 1996

Another NeuroSearch compound for nerve degeneration

Sep. 6, 1996

NeuroSearch compound for the treatment of brain damage

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...